Ctxr sec filings

Author: uxln

August undefined, 2024

WebCitius Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 04/08/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider ... WebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News …

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebThis table shows the interest rate that must be paid by a short seller of US:CTXR to the lender of that security. This fee is shown as an annual percentage rate (APR). Lenders are funds or individuals that own the … how to remove dba from ein

Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR)

WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 10-K Annual Report Thu Dec 22 2024 Earnings Press Release 10-K Annual Report 10-K YoY Changes Citius … WebCitius Pharmaceuticals, Inc. Common Stock (CTXR) SEC Filings Nasdaq SEC Filings: CTXR Edit my quotes Citius Pharmaceuticals, Inc. Common Stock (CTXR) 0 Add to Watchlist Add to... WebBack to CTXR Overview Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt... how to remove daylilies from garden

CTXR Institutional Ownership and Shareholders - Citius …

CTXR 13F Hedge Fund and Asset Management Owners

WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Saturday, December 31, 2024 WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. how to remove dazzle nail polishWebCTXR / Citius Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 EXTENDED Overview Owners Insiders Short Interest Options Filings Financials … how to remove dcfwinservice

"WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter " - Ctxr sec filings

Ctxr sec filings

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

WebMar 31, 2024 · Latest SEC filings for Citius Pharmaceuticals, Inc. (CTXR). Seeking Alpha - Go to Homepage Entering text into the input field will update the search … Webctxrex1012.htm exhibit 10.12 placement agent's unit warrants neither these securities nor the securities issuable upon exercise of these securities have been registered with the …

Did you know?

WebApr 6, 2024 · Citius Pharmaceuticals, Inc. SEC Filing - Quarterly Report (10-Q) February 10, 2024 SEC FilingsFri, Feb. 10 Citius Pharmaceuticals, Inc. SEC Filing - Proxy … WebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External …

WebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024 WebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market ￻ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

WebApr 3, 2024 · ctxr The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 … WebApr 6, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-018307 Submitted to the SEC: Wed Apr 06 2024 8:11:08 AM EST Accepted by the SEC: Wed Apr 06 2024 Period: Wednesday, April 6, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External …

WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc

WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … how to remove ddq from reactionWebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. how to removed by default widget in zerif proWebInstitutional Ownership and Shareholders Citius Pharmaceuticals Inc (US:CTXR) has 94 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). … how to remove dch driversWebApr 6, 2024 · View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. how to remove dbrand skin from laptopWebAug 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly Report for the period ending Thursday, June 30, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Aug 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. how to remove dch drivers nicehashWebFind the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. how to remove dbxsvcWebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … how to remove dcfi on microsoft 1943